Ranolazine is an anti-anginal medication classified as a late sodium current inhibitor, indicated for the treatment of chronic angina pectoris by reducing myocardial oxygen demand. To support the rigorous… Read more






![Chemical structure of 2,2'-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)]acetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F380204-72-8-22-Piperazine-14-diylbisN-26-dimethylphenylacetamide.png&w=3840&q=75)

![Chemical structure of 2-[(2-Methoxyphenoxy)methyl]oxirane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2210-74-4-2-2-Methoxyphenoxymethyloxirane.png&w=3840&q=75)
![Chemical structure of 2-[(2-Methoxyphenoxy)methyl]oxirane-d3](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1054624-90-6-2-2-Methoxyphenoxymethyloxirane-d3.png&w=3840&q=75)


































![Chemical structure of α,α'-Bis[(2-Methoxyphenoxy)methyl]-1,4-piperazinediethano](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F333749-57-8-Bis2-Methoxyphenoxymethyl-14-piperazinediethano.png&w=3840&q=75)
Ranolazine is an anti-anginal medication classified as a late sodium current inhibitor, indicated for the treatment of chronic angina pectoris by reducing myocardial oxygen demand. To support the rigorous demands of pharmaceutical quality control, this category provides a comprehensive range of high-quality reference standards, including the parent active pharmaceutical ingredient, its stereoisomers, and various process-related or degradation impurities. Laboratories rely on these materials for accurate impurity profiling, supporting the identification and quantification of synthetic intermediates and potential contaminants in accordance with international regulatory guidelines. Furthermore, the inclusion of stable isotope labelled compounds enables precise analytical method validation and recovery studies during bioanalytical testing. By providing structurally characterized standards, these compounds assist researchers and quality assurance teams in ensuring product safety, therapeutic efficacy, and compliance with pharmacopeial specifications throughout the drug development and manufacturing lifecycle.